|
Jan 25
|
Is Johnson & Johnson (JNJ) The Best Bear Market Stock To Invest In Now?
|
|
Jan 25
|
Is Johnson & Johnson (JNJ) Among The Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years?
|
|
Jan 25
|
These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024
|
|
Jan 24
|
Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now?
|
|
Jan 24
|
5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025
|
|
Jan 24
|
Disasters Spawn New Businesses. The California Wildfires Will Do the Same.
|
|
Jan 23
|
Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?
|
|
Jan 23
|
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
|
|
Jan 23
|
Biotech Venture Investors Optimistic, But Uncertainties Persist
|
|
Jan 23
|
Jim Cramer Likes Johnson & Johnson (JNJ) and the Kenvue Spin-Off – Here’s Why
|
|
Jan 23
|
Johnson & Johnson Likely to Achieve 2025 Targets, RBC Says
|
|
Jan 23
|
Is Johnson & Johnson (JNJ) the Best Halal Dividend Stock to Invest In Now?
|
|
Jan 23
|
How HP, Johnson & Johnson And Rexford Industrial Realty Can Put Cash In Your Pocket
|
|
Jan 23
|
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
|
|
Jan 23
|
Why Is Prem Watsa Bullish On Johnson & Johnson (JNJ) Now?
|
|
Jan 23
|
Johnson & Johnson champions first-ever Canadian consensus paper identifying critical gaps in psoriasis care for patients with skin of colour
|
|
Jan 23
|
J&J Stock Dips 2% Despite Q4 Earnings Beat
|
|
Jan 23
|
Findings from pivotal nipocalimab Phase 3 study in a broad antibody positive population of people living with generalized myasthenia gravis (gMG) published in The Lancet Neurology
|
|
Jan 23
|
This Is 1 of the Healthiest High-Yielding Dividend Stocks You'll Find
|
|
Jan 23
|
J&J is all in on tau-targeted Alzheimer’s candidates. Will the approach lead to more effective treatments?
|